Phase II
There were plenty of clinical trial announcements this week. Here’s a look.
As the J.P. Morgan Healthcare Conference winds down for 2020, one of the big topics was the general lack of big deals. Still, there were some general trends and for today, some news.
Companies from across the globe provide updates to their business and pipeline.
With the J.P. Morgan Healthcare Conference in full swing, companies did not waste time in announcing deals and providing updates to their pipelines. BioSpace takes a look at some of the announcements made on day one of the annual conference in the Bay Area.
The first full business week of the new year began with plenty of clinical trial news. Here’s a look.
Not waiting for the start of the annual J.P. Morgan Healthcare Conference, Eli Lilly announced it will acquire California-based Dermira, Inc. in an all-cash deal for $1.1 billion.
It can be a bit difficult to predict exactly what the big stories out of the JP Morgan Healthcare Conference are going to be. There’s no telling if some surprise deal will take the air out of the room, but here’s a look at some of the top presentations.
Fibrodysplasia ossificans progressive (FOP disease) treatment is almost here and it is showing promising results. This article provides deep insights into it.
Even with the holiday week, there was still some clinical trial news coming out. Here’s a look.
As a result, the company is abandoning the development of the product for this indication and focusing the asset on liver diseases.
PRESS RELEASES